Streetbeat News

Equity Actions

PLX

Protalix BioTherapeutics (PLX) is set to join the Russell 3000 Index, which may increase its visibility and attract more investors.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 10:52 am

USFD

US Foods announced a secondary public offering of 17.4 million shares of common stock and a concurrent $150 million share repurchase. The offering is by KKR Fresh Holdings L.P., and US Foods will not receive any proceeds from the sale.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 10:41 am

VIPS

Vipshop Holdings' board of directors approved a $500 million increase in its share repurchase program, allowing the company to buy back up to $1 billion of its ADSs or Class A ordinary shares.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:16 am

HUYA

Huya has announced that Lingdong Huang is no longer serving as director and chairman of the board. Songtao Lin has been appointed as the new chairman, effective immediately.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 9:09 am

NAVB

Navidea Biopharmaceuticals has raised $1.1 million through the sale of preferred shares to new and existing investors. The funds will be used to support the completion of the company's NAV3-32 and NAV3-33 trials.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:25 am

GH

Guardant Health has priced an upsized public offering of 12.5 million shares at $28.00 per share, raising gross proceeds of $350 million.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:11 am

AGRX

Agile Therapeutics has priced its public offering of 1.89 million shares, along with accompanying common stock warrants, at $3.9551 per share, raising approximately $7.5 million in gross proceeds.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:09 am

ICVX

Icosavax (NASDAQ:ICVX) announced a registered direct offering of 8.37M shares at $8.10 per share, expecting to raise $67.8M. The financing was led by TCGX, with participation from Logos Capital and Vivo Capital.

Portfolio Pulse from Charles Gross

May 22, 2023 | 9:55 pm

BHB

Bar Harbor Bankshares (NYSE:BHB) announces a stock repurchase plan for up to 756,000 shares of its outstanding common stock, representing approximately 5% of its shares as of April 30, 2023. The plan is authorized to last no longer than 12 months.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 9:27 pm

BSGM

BioSig Technologies Inc entered a securities purchase agreement on May 16, selling 1.8 million shares at $1.3905 per share.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 9:10 pm